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Abstract
Background: There is accumulating evidence that obesity is closely associated with an impaired free fatty acid
metabolism as well as with insulin resistance and inflammation. Excessive fatty acid uptake mediated by fatty acid
translocase CD36 plays an important role in hepatic steatosis. Molecular hydrogen has been shown to attenuate
oxidative stress and improve lipid, glucose and energy metabolism in patients and animal models of hepatic
steatosis and atherosclerosis, but the underlying molecular mechanisms remain largely unknown.
Methods: Human hepatoma HepG2 cells were exposed to palmitate-BSA complex after treatment with or without
hydrogen for 24 h. The fatty acid uptake was measured by using spectrofluorometry and the lipid content was
detected by Oil Red O staining. JNK phosphorylation and CD36 expression were analyzed by Western blot and real-
time PCR analyses.
Results: Pretreatment with hydrogen reduced fatty acid uptake and lipid accumulation after palmitate overload in
HepG2 cells, which was associated with inhibition of JNK activation. Hydrogen treatment did not alter CD36 mRNA
expression but reduced CD36 protein expression.
Conclusion: Hydrogen inhibits fatty acid uptake and lipid accumulation through the downregulation of CD36 at
the protein level in hepatic cultured cells, providing insights into the molecular mechanism underlying the
hydrogen effects in vivo on lipid metabolism disorders.
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Background
Obesity and its associated disorders such as type 2 dia-
betes, coronary heart diseases and non-alcoholic fatty
liver disease (NAFLD) are currently global health prob-
lems. There is accumulating evidence that obesity is
closely associated with impaired free fatty acid (FFA)
metabolism as well as insulin resistance and inflamma-
tion [1]. Excessive release of FFA from visceral fat adipo-
cytes leads to the production of inflammatory and
proatherogenic proteins through activation of the NFκB
and c-Jun NH2-terminal kinase (JNK) pathways in
skeletal muscle, liver and endothelial cells, and promotes
atherosclerotic vascular disease (ASVD) and NAFLD.
Fatty acid translocase CD36 mediates uptake of FFA
from circulation and intracellular transport of long-
chain fatty acids in diverse cell types such as monocytes,
platelets, macrophages, microvascular endothelial cells,
adipocytes, muscle cells, enterocytes, and hepatocytes
[2]. Mice deficient of CD36 exhibit defective uptake and
utilization of fatty acids. Excessive fatty acid uptake me-
diated by CD36 plays an important role in hepatic
steatosis [3]. The expression level of CD36 is very low in
normal liver tissues [4], but is drastically increased in
the liver tissues of high-fat diet (HFD)-induced fatty liver
mice and those of human NAFLD. Conversely, forced
expression of CD36 in liver causes hepatic steatosis in
the absence of HFD [5]. There is extensive evidence
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showing that CD36 plays significant roles in hepatic
steatosis, suggesting that CD36 can be a potential drug
target against NAFLD.
Since the first report in 2007, which demonstrated the
effect of molecular hydrogen on brain infarction [6],
hydrogen has been shown to protect against a variety of
diseases including oxidative stress-related diseases, in-
flammation and allergy in in vivo and in vitro models as
well as in humans [7]. In the metabolic diseases, hydro-
gen attenuates oxidative stress and improves lipid, glu-
cose and energy metabolism in patients and animal
models of hepatic steatosis and atherosclerosis, but the
underlying molecular mechanisms remain largely un-
known [8-11]. Although the hydrogen effects have been
ascribed to a selective scavenging of hydroxyl radicals,
we previously reported that hydrogen attenuates type I
allergy via inhibiting intracellular signaling pathways,
providing the first evidence that hydrogen modulates
signaling pathways [12]. We also demonstrated that
hydrogen suppresses LPS/IFNγ-induced phosphorylation
of apoptosis signal-regulating kinase 1 (ASK1) and its
downstream signaling molecules, p38, JNK and NFκB,
resulting in inhibition of iNOS expression and NO pro-
duction in macrophages [13]. Based on these findings,
we proposed a hypothesis that hydrogen may act as a
modulator of signaling pathways, thereby exhibiting pro-
tective effects against various diseases. Consistent with
our hypothesis, it has been recently reported that hydro-
gen inhibits signaling pathways in animal models of acute
liver injury [14] and amyloid-beta-induced Alzheimer’s
disease [15].
In the present study, in order to understand the
underlying mechanisms of hydrogen effects on lipid me-
tabolism disorders and atherosclerosis, we examined if
hydrogen could attenuate fatty acid intake and lipid ac-
cumulation caused by palmitate overload in human
hepatoma HepG2 cells. We then investigated whether
hydrogen could modulate signaling pathways after
palmitate overload as well as CD36 expression after
hydrogen treatment in this cell culture model of hepatic
steatosis.
Materials and methods
Cell culture and hydrogen treatment
Human hepatoma HepG2 cells were purchased from
RIKEN BioResource Center (Tsukuba, Japan) and cul-
tured in DMEM containing 10% heat-inactivated FBS in
a humidified atmosphere of 5% CO2 at 37°C. Prior to
hydrogen treatment, cells were starved in serum-free
DMEM for 24 h. Hydrogen treatment was performed as
described previously [12]. Briefly, cells were cultured in
DMEM containing 0.67% (w/v) fatty acid-free BSA
(Roche, Penzberg, Germany) under a humidified condition
of 75% H2, 20% O2 and 5% CO2, or 95% air and 5% CO2
in a small aluminum bag. After treatment with or without
hydrogen for 24 h, cells were treated with 0.67% fatty
acid-free BSA or with 0.3 and 1.0 mM sodium palmitate
(Sigma, St. Louis, MO, USA)-BSA complex (containing
0.67% fatty acid-free BSA) for 24 h to analyze the lipid
content. Cells were also treated with fatty acid-free BSA
or with 0.3 mM sodium palmitate-BSA complex for
120 min to analyze the protein phosphorylation.
Cell viability assay
After treatment with or without hydrogen for 24 h, cell via-
bility was determined calorimetrically using the Cell
Counting kit (WST-1 assay: Wako, Osaka, Japan) according
to the manufacturer’s protocol.
Measurement of fatty acid uptake and lipid content
Fatty acid uptake assay was performed as described by
Liao et al. [16] with slight modification. After treatment
with or without hydrogen for 24 h, cells were washed
twice with Hank’s balanced salt solution (HBSS: Gibco,
Langley, OK, USA) and incubated in HBSS containing
0.1% fatty acid-free BSA and 0.5 μg/ml BODIPY FL C16
(Molecular Probes, Eugene, OR, USA) for 15 min at
37°C. After washing twice with ice-cold HBSS containing
0.2% BSA, cells were detached with 10 mM EDTA/PBS
and subjected to the measurement of fluorescence using
the MT-600 F fluorescence microplate reader (Corona
Electric, Hitachinaka, Japan). The relative BODIPY FL
C16 uptake was expressed as fluorescence intensity in
cells relative to the total amount of protein. To quantify
the lipid content, cells were stained with Oil Red O for
10 min and then dye was extracted and measured as de-
scribed previously [17].
CT-B binding assay
After treatment with or without hydrogen for 24 h, cells
were washed twice with HBSS and incubated in HBSS
containing 0.1% fatty acid-free BSA and 0.5 μg/ml
Alexa594-conjugated cholera toxin B subunit (CT-B;
Molecular Probes) for 1 h at 37°C. After washing twice
with ice-cold HBSS containing 0.2% BSA, cells were
subjected to the measurement of fluorescence using the
fluorescence microplate reader.
Real-time RT-PCR analysis
Total RNA was extracted from cells by Isogen II (Wako)
followed by DNase I treatment. cDNA was synthesized
using the PrimeScript RT reagent kit (Takara, Ohtsu,
Japan) and quantitative real-time PCR was performed
using SYBR Premix Ex Taq II (Tli RNaseH Plus: Takara)
and the real-time thermal cycler Dice (Takara). Primer
sets were as follows: GAPDH, 5’-CCACATCGCTCAGA
CACCAT-3’ and 5’-GCAACAATATCCACTTTACCAG
AGTTAA -3’ [18]; CD36, 5’-TGGAACAGAGGCTGAC
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AACTT-3’ and 5’-TTGATTTTGATAGATATGGGATG
C-3’. The expression level of CD36 gene was determined
using the comparative Ct method and normalized to that
of GAPDH.
Western blot analysis
Whole cell extracts were prepared by using RIPA buffer
containing the protein inhibitor cocktail (Roche) and the
phosphatase inhibitor cocktail (Sigma). Samples were
subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and electroblotted onto
PVDF membranes. Membranes were incubated with a
primary antibody, anti-SAPK/JNK, anti-phospho-SAPK/
JNK (Thr183/Tyr185), anti-GAPDH (Cell Signaling
Technology, Beverly, MA, USA) or anti-CD36 (GenTex,
Irvine, CA, USA), followed by incubation with a horse-
radish peroxidase-conjugated anti-rabbit secondary anti-
body. Protein bands were detected using the ECL Plus
(GE Healthcare, Little Chalfont, UK) and the chemilu-
minescence imager LAS 4000 (Fujifilm, Tokyo, Japan).
Statistical analysis
Results were expressed as mean ± SD of three independ-
ent experiments unless otherwise noted. Data were ana-
lyzed using Student’s t-test. A value of p < 0.05 was
considered significant.
Results and discussion
Hydrogen does not affect viability of HepG2 cells
We determined the effects of hydrogen on viability and
morphology of HepG2 cells under the experimental condi-
tion we described previously [12]. After serum deprivation
for 24 h, cells were treated with hydrogen in DMEM
containing fatty acid-free BSA for 24 h and then subjected
to cell viability assay. Hydrogen treatment did not affect
cell viability (Figure 1) and morphology (data not shown).
This is consistent with our previous finding that hydrogen
did not influence cell viability and morphology of cultured
cells when administered according to our protocol [12,13].
These results suggest that hydrogen is unlikely to induce
cell death or proliferation in subsequent experiments.
Hydrogen reduces fatty acid uptake and lipid
accumulation
In patients with type 2 diabetes, oral intake of hydrogen-
rich water is associated with the reduction of serum con-
centrations of oxidized low-density lipoprotein (LDL)
and FFA [9], both of which are CD36 ligands. Adminis-
tration of hydrogen-rich water prevents atherosclerosis
in apolipoprotein E knockout mice, a model of the spon-
taneous development of atherosclerosis [19]. However,
the molecular mechanisms of hydrogen to improve lipid
metabolism and atherosclerosis remain largely unknown.
In an attempt to investigate the underlying mechanisms,
we first examined whether hydrogen could exhibit bene-
ficial effects on lipid metabolism in a cell culture model
of hepatic steatosis. According to a previous report by
Gómez-Lechón et al. [20], an overload of fatty acids
leads to lipid accumulation in HepG2 cells. We thus
treated HepG2 cells with 0.3 or 1.0 mM palmitate-BSA
for 24 h and then performed Oil Red O staining to de-
tect the intracellular triglyceride (TG) content. Indeed,
incubation of the cells with palmitate-BSA developed a
clear increase of lipid accumulation in the cytosol com-
pared with the BSA control (Figure 2A). We then stud-
ied if pretreatment with hydrogen for 24 h could affect
lipid accumulation by palmitate overload. As shown in
Figure 2A, intracellular lipid accumulation caused by 0.3
or 1.0 mM palmitate was significantly reduced by hydro-
gen treatment. In apolipoprotein E knockout mice, ath-
erosclerotic lesions were decreased by hydrogen as
judged by Oil Red O staining of macrophages in serial
sections of the aorta [19]. Our results and others suggest
that molecular hydrogen is capable of reducing fat accu-
mulation in in vitro and in vivo models of metabolic
diseases.
In hepatocytes, FFA is converted to TG, which is used
for production of very low-density lipoprotein (VLDL), a
class of lipoproteins. VLDL transports TG from the liver
and intestine to adipose and muscle tissues, but excess
TG is stored in lipid droplets [3]. The cellular lipid
content in part depends on FFA uptake through trans-
membrane transport. In order to examine if hydrogen
could influence FFA uptake, cells were treated with a
Figure 1 Effects of hydrogen on viability of HepG2 cells. After
serum starvation, HepG2 cells were treated with or without
hydrogen for 24 h and cell viability was determined by the
WST-1 assay.
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BODIPY-labeled fluorescent fatty acid analog, BODIPY
FL C16, for 15 min after treatment with or without
hydrogen for 24 h. After washing, intracellular fluores-
cence was measured. As shown in Figure 2B, the
fluorescent-labeled palmitate uptake was significantly
reduced by hydrogen treatment. Taken together, these
results suggest that hydrogen inhibits fatty acid uptake
and lipid accumulation after palmitate overload in
HepG2 cells.
Hydrogen inhibits palmitate-induced phosphorylation of
JNK
In an attempt to elucidate molecular mechanisms under-
lying the reduction by hydrogen of fatty acid uptake and
lipid accumulation in HepG2 cells, we investigated the
effect of hydrogen on palmitate-induced activation of
signaling pathways. Since Gao et al. have recently
reported that FFA induces hepatic insulin resistance
through JNK and p38 MAPK (mitogen-activated protein
kinases) pathways [21], we analyzed JNK and p38 activa-
tion after palmitate treatment in HepG2 cells. As shown
in Figure 3A, phosphorylation of JNK caused by palmi-
tate overload was attenuated by hydrogen treatment. In
contrast, activation of p38 was not affected by hydrogen
(data not shown). Among the physiological responses in-
duced by fatty acid overload, JNK activation has been
shown to be the most responsible for palmitate-induced
oxidative stress and HFD-induced hepatic steatosis
[22,23]. Hence, our results suggest that inhibition of JNK
activation by hydrogen may contribute to the attenu-
ation of palmitate-induced hyperlipogenesis.
Hydrogen downregulates protein expression of CD36
Binding of CT-B to ganglioside GM1 is a marker to
identify lipid rafts, which are membrane microdomains
enriched in cholesterol and sphingolipid [24]. There are
several evidences for the correlation of the level of FFA
uptake with the expression level of FFA transporter pro-
teins and with the integrity of lipid rafts [25]. In order to
examine if hydrogen affected the lipid raft integrity in
HepG2 cells, we measured the intensity of fluorescent-
labeled CT-B binding after hydrogen treatment using a
Figure 2 Effects of hydrogen on fatty acid uptake and lipid
accumulation in HepG2 cells. (A) After treatment with or without
hydrogen for 24 h, cells were exposed to 0.3 mM palmitate-BSA (PA)
for 24 h, and then stained with Oil Red O. The Oil Red O content
was measured at a wavelength of 540 nm. Data are expressed as
mean ± SD (n = 6) (***p < 0.001). (B) After treatment with or without
hydrogen for 24 h, cells were exposed to BODIPY-FL C16 for 15 min
and fluorescence intensity was measured (*p < 0.05).
Figure 3 Effects of hydrogen on JNK phosphorylation and lipid
raft integrity in HepG2 cells. (A) After treatment with or without
hydrogen for 24 h, cells were incubated in the presence of
palmitate-BSA (0.3 mM) for indicated time periods, and cell lysates
were harvested and subjected to Western blot analysis for JNK and
phospho-JNK proteins. (B) After treatment with or without hydrogen
for 24 h, HepG2 cells were exposed to Alexa594-CT-B for 1 h at 37°C
and fluorescent intensity was measured with the fluorescence
microplate reader.
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fluorescence microplate reader. As shown in Figure 3B,
hydrogen treatment did not affect the lipid raft integrity.
These findings suggested the possibility that inhibition
of FFA uptake by hydrogen might be due to the altered
expression of FFA transporter proteins such as CD36.
To verify whether hydrogen attenuated palmitate-
induced lipid accumulation in HepG2 cells through
regulation of CD36 expression, the expression level of
CD36 after hydrogen treatment was evaluated by real-
time PCR and Western blot analyses. Unexpectedly,
CD36 mRNA expression was not altered by hydrogen
treatment (Figure 4A), but CD36 protein expression was
significantly downregulated by hydrogen (Figure 4B). It
has been previously reported that a non-physiological
short chain ceramide, C2-ceramide, reduces CD36 ex-
pression at protein levels but not at mRNA levels in
monocytes and macrophages [26]. Furthermore, the
antiretroviral protease inhibitor, ritonavir, which inhibits
proteasome activity in THP-1 cells, increases CD36 pro-
tein levels but not mRNA levels, followed by increased
oxLDL uptake and cholesterol levels [27]. These findings
suggest that the reduction of CD36 protein expression
by hydrogen treatment may involve post-transcriptional
events including inhibition of protein translation or en-
hancement of protein degradation. Ubiquitination plays
an important role in acute regulation of many membrane
protein levels. Smith et al. found that CD36 protein was
ubiquitinated on lysines 469 and 472 on its C-terminal do-
main [28]. This process is enhanced by fatty acid, indicat-
ing the negative feedback mechanism of CD36 expression.
It would be possible that hydrogen might activate the
ubiquitin-proteasome system and downregulate CD36
expression. A recent report also showed that Parkin
mono-ubiquitinates CD36, stabilizing and increasing
CD36 [29]. If hydrogen could inhibit the activity or ex-
pression of Parkin, CD36 might be poly-ubiquitinated
and rapidly degraded, the possibility of which remains
to be studied.
Hydrogen downregulates CD36 protein expression and
thereby inhibits palmitate-induced phosphorylation of
JNK
In the present study, hydrogen treatment results in
downregulation of CD36 protein expression in HepG2
cells, which inhibits fatty acid uptake when cells are
subjected to palmitate overload. Therefore, inhibition of
palmitate-induced phosphorylation of JNK is likely to be
the consequence of the reduced uptake of fatty acid.
Our results suggest that downregulation of CD36 ex-
pression by hydrogen pretreatment may be the primary
mechanism against hepatic steatosis in this in vitro
model.
Finally, it is worth to note that we investigated the mo-
lecular mechanisms of the hydrogen effects on lipid
metabolism using the cell culture system we previously
developed. To keep the hydrogen concentration high in
the medium, cells are cultured under the condition of
75% H2, 20% O2, and 5% CO2. A recent report, however,
demonstrated that oral intake of water containing a rela-
tively lower concentration of hydrogen was effective in an
animal model of Parkinson’s disease [30]. Furthermore,
the increase in hydrogen concentration in the body after
taking hydrogen water should be transient. In order to
precisely recapitulate the hydrogen effects in vivo, a novel
cell culture system needs to be developed in which
Figure 4 Effects of hydrogen on CD36 expression in HepG2
cells. After treatment with or without hydrogen for 24 h, total RNA
was harvested and quantitative real-time RT-PCR was performed for
CD36 mRNA (A), and cell lysates were harvested and Western blot
analysis was performed for CD36 protein (B). GAPDH was used as an
internal control, and the CD36 protein level (fold) was evaluated by
densitometry (*p < 0.05).
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concentration and timing of hydrogen treatment can be
readily changed.
Conclusions
Hydrogen downregulates the protein expression of
CD36, and inhibits fatty acid uptake and lipid accumula-
tion in HepG2 cells. As the consequence, hydrogen may
modulate signal transduction such as the JNK pathway.
Our results provide insights into the molecular mechan-
ism underlying the hydrogen effects on lipid metabolism
disorders such as hepatic steatosis and NAFLD.
Abbreviations
NAFLD: Non-alcoholic fatty liver disease; FFA: Free fatty acid; JNK: c-Jun NH2-
terminal kinase; ASVD: Atherosclerotic vascular disease; HFD: High-fat diet;
ASK1: Apoptosis signal-regulating kinase 1; HBSS: Hank’s balanced salt
solution; CT-B: Cholera toxin B subunit; SDS-PAGE: Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis; LDL: Low-density lipoprotein;
TG: Triglyceride; VLDL: Very low-density lipoprotein; MAPK: Mitogen-activated
protein kinases.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IO, KO, MI and YN participated in the design of the study. MiI and TI set up
the system of hydrogen treatment in in vitro culture system. AI, MiI, RT and
YF carried out experiments. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported in part by Grant-in-aid for Scientific Research
(22300244 to Masafumi Ito) from the Ministry of Education, Culture, Sports,
Science, and Technology of Japan.
Author details
1Department of Embryology, Institute for Developmental Research, Aichi
Human Service Center, 713-8 Kamiya-Cho, Kasugai, Aichi 480-0392, Japan.
2Division of Neurogenetics, Center for Neurological Diseases and Cancer,
Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku,
Nagoya, Aichi 466-8550, Japan. 3Faculty of Agriculture, Kinki University,
3327-204 Nakamachi, Nara, Nara 631-0052, Japan. 4Department of Urology,
Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, Gifu
501-1193, Japan. 5Research Team for Mechanism of Aging, Tokyo
Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi, Tokyo
173-0015, Japan. 6Department of Food and Health, Tokai Gakuin University,
5-68 Naka-kirinocho, Kakamigahara, Gifu 504-8511, Japan. 7Research Team for
Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, 35-2
Sakae-cho, Itabashi, Tokyo 173-0015, Japan.
Received: 25 December 2012 Accepted: 25 February 2013
Published: 1 March 2013
References
1. Boden G: Obesity and free fatty acids (FFA). Endocrinol Metab Clin North
Am 2008, 37:635–646.
2. Su X, Abumrad NA: Cellular fatty acid uptake: a pathway under
construction. Trends Endocri Metab 2009, 20:72–77.
3. Bradbury MW: Lipid metabolism and liver inflammation. I. Hepatic fatty
acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver
Physiol 2006, 290:G194–G198.
4. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA: Cloning of a
Rat adipocyte membrane protein implicated in binding or transport of
long-chain fatty acids that is induced during preadipocyte
differentiation. J Biol Chem 1993, 268:17665–17668.
5. Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE,
Dyck JR: Increased hepatic CD36 expression contributes to dyslipidemia
associated with diet-induced obesity. Diabetes 2007, 56:2863–2871.
6. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K,
Katsura K, Katayama Y, Asoh S, Ohta S: Hydrogen acts as a therapeutic
antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med
2007, 13:688–694.
7. Ohta S, Nakao A, Ohno K: The 2011 medical molecular hydrogen
symposium: an inaugural symposium of the journal medical Gas
research. Med Gas Res 2011, 1:10.
8. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N,
Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T:
Supplementation of hydrogen-rich water improves lipid and glucose
metabolism in patients with type 2 diabetes or impaired glucose
tolerance. Nutr Res 2008, 28:137–143.
9. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N: Effectiveness of
hydrogen rich water on antioxidant status of subjects with potential
metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 2010,
46:140–149.
10. Kamimura N, Nishimaki K, Ohsawa I, Ohta S: Molecular hydrogen improves
obesity and diabetes by inducing hepatic FGF21 and stimulating energy
metabolism in db/db mice. Obesity 2011, 19:1396–1403.
11. Kawai D, Takaki A, Nakatsuka A, Wada J, Tamaki N, Yasunaka T, Koike K,
Tsuzaki R, Matsumoto K, Miyake Y, Shiraha H, Morita M, Makino H,
Yamamoto K: Hydrogen-rich water prevents progression of nonalcoholic
steatohepatitis and accompanying hepatocarcinogenesis in mice.
Hepatology 2012, 56:912–921.
12. Itoh T, Fujita Y, Ito M, Masuda A, Ohno K, Ichihara M, Kojima T, Nozawa Y,
Ito M: Molecular hydrogen suppresses FceRI-mediated signal
transduction and prevents degranulation of mast cells. Biochem Biophys
Res Commun 2009, 389:651–656.
13. Itoh T, Hamada N, Terazawa R, Ito M, Ohno K, Ichihara M, Nozawa Y, Ito M:
Molecular hydrogen inhibits lipopolysaccharide/interferon γ-induced
nitric oxide production through modulation of signal transduction in
macrophages. Biochem Biophys Res Commun 2011, 411:143–149.
14. Sun H, Chen L, Zhou W, Hu L, Li L, Tu Q, Chang Y, Liu Q, Sun X, Wu M,
Wang H: The protective role of hydrogen-rich saline in experimental liver
injury in mice. J Hepatol 2011, 54:471–480.
15. Wang C, Li J, Liu Q, Yang R, Zhang JH, Cao YP, Sun XJ: Hydrogen-rich
saline reduces oxidative stress and inflammation by inhibit of JNK and
NF-kB activation in a rat model of amyloid-beta-induced Alzheimer’s
disease. Neurosci Lett 2011, 491:127–132.
16. Liao J, Sportsman R, Harris J, Stahl A: Real-time quantification of fatty acid
uptake using a novel fluorescence assay. J Lipid Res 2005, 46:597–602.
17. Iio A, Ohguchi K, Inoue H, Maruyama H, Araki Y, Nozawa Y, Ito M: Ethanolic
extracts of Brazilian red propolis promote adipocyte differentiation
through PPARγ activation. Phytomedicine 2010, 17:974–979.
18. Iio A, Ohguchi K, Maruyama H, Tazawa S, Araki Y, Ichihara K, Nozawa Y, Ito
M: Ethanolic extracts of Brazilian red propolis increase ABCA1 expression
and promote cholesterol efflux from THP-1 macrophages. Phytomedicine
2012, 19:383–388.
19. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S: Consumption of
hydrogen water prevents atherosclerosis in apolipoprotein E knockout
mice. Biochem Biophys Res Commun 2008, 377:1195–1198.
20. Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV,
O’Connor JE: A human hepatocellular in vitro model to investigate
steatosis. Chem Biol Interact 2007, 165:106–116.
21. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J:
The effects of palmitate on hepatic insulin resistance are mediated by
NADPH Oxidase 3-derived reactive oxygen species through JNK and p38
MAPK pathways. J Biol Chem 2010, 285:29965–29973.
22. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M,
Hotamisligil GS: A central role for JNK in obesity and insulin resistance.
Nature 2002, 420:333–336.
23. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE,
Czaja MJ: JNK1 but not JNK2 promotes the development of
steatohepatitis in mice. Hepatology 2006, 43:163–172.
24. Harder T, Scheiffele P, Verkade P, Simons K: Lipid domain structure of the
plasma membrane revealed by patching of membrane components.
J Cell Biol 1998, 141:929–942.
25. Ehehalt R, Füllekrug J, Pohl J, Ring A, Herrmann T, Stremmel W:
Translocation of long chain fatty acids across the plasma membrane—
lipid rafts and fatty acid transport proteins. Mol Cell Biochem 2006,
284:135–140.
Iio et al. Medical Gas Research 2013, 3:6 Page 6 of 7
http://www.medicalgasresearch.com/content/3/1/6
26. Luan Y, Griffiths HR: Ceramides reduce CD36 cell surface expression and
oxidised LDL uptake by monocytes and macrophages. Arch Biochem
Biophys 2006, 450:89–99.
27. Munteanu A, Zingg JM, Ricciarelli R, Azzi A: CD36 overexpression in
ritonavir-treated THP-1 cells is reversed by α-tocophenol. Free Rad Biol
Med 2005, 38:1047–1056.
28. Smith J, Su X, El-Maghrabi R, Stahl PD, Abumrad NA: Opposite regulation
of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid
uptake. J Bio Chem 2008, 283:13578–13585.
29. Kim KY, Stevens MV, Akter MH, Rusk SE, Huang RJ, Cohen A, Noguchi A,
Springer D, Bocharov AV, Eggerman TL, Suen DF, Youle RJ, Amar M,
Remaley AT, Sack MN: Parkin is a lipid-responsive regulator of fat uptake
in mice and mutant human cells. J Clin Invest 2011, 121:3701–3712.
30. Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, Sakumi K,
Yamakawa Y, Kido MA, Takaki A, Katafuchi T, Tanaka Y, Nakabeppu Y, Noda
M: Hydrogen in drinking water reduces dopaminergic neuronal loss in
the 1-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine mouse model of
Parkinson’s disease. PLoS One 2009, 4:e7247.
doi:10.1186/2045-9912-3-6
Cite this article as: Iio et al.: Molecular hydrogen attenuates fatty acid
uptake and lipid accumulation through downregulating CD36
expression in HepG2 cells. Medical Gas Research 2013 3:6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Iio et al. Medical Gas Research 2013, 3:6 Page 7 of 7
http://www.medicalgasresearch.com/content/3/1/6
